Current and future treatment for alcoholic-related liver diseases
- Authors
- Yoon, Eileen Laurel; Kim, Won
- Issue Date
- Aug-2023
- Publisher
- WILEY
- Keywords
- alcoholic hepatitis; gut–liver axis; inflammation; prednisolone; regeneration
- Citation
- JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, v.38, no.8, pp.1218 - 1226
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Volume
- 38
- Number
- 8
- Start Page
- 1218
- End Page
- 1226
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/191915
- DOI
- 10.1111/jgh.16257
- ISSN
- 0815-9319
- Abstract
- The socioeconomic burden of alcohol-related liver disease has been increasing worldwide. Its prevalence is underestimated, and patients with alcohol-related liver disease are rarely diagnosed in the earlier phase of the disease spectrum. Alcoholic hepatitis is a distinct syndrome with life-threatening signs of systemic inflammation. In severe alcoholic hepatitis, prednisolone is indicated as the first-line treatment even with the possibility of various complications. Early liver transplantation can be another option for highly selected patients with a null response to prednisolone. Most importantly, abstinence is the mainstay of long-term care, but relapse is frequent among patients. Recent findings on the pathogenesis of alcoholic hepatitis have enabled us to discover new therapeutic targets. Preventing hepatic inflammation, reducing oxidative stress, improving gut dysbiosis, and enhancing liver regeneration are the main targets of emerging therapies. Herein, we review the pathogenesis, current treatment, and barriers to successful clinical trials of alcoholic hepatitis. Additionally, clinical trials for alcoholic hepatitis, either ongoing or recently completed, will be briefly introduced.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/191915)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.